HIGHLIGHTS
- who: Indicates Poor Prognosis and collaborators from the Department of Hepatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China have published the research: Low Complement Factor H-Related 3 (CFHR3) Expression Indicates Poor Prognosis and Immune Regulation in Cholangiocarcinoma, in the Journal: Journal of Oncology of 12/09/2022
- what: The authors investigated the usefulness of CFHR3 in the diagnostic stage and CCA prediction.
- how: With the aid of the STRING database the authors carried out the PPI network analysis of CFHR3 and CFHR3-related genes . It was surprising that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.